- Clustering of longitudinal data of a mixed type2022 | Faculty of Mathematics and Physics
- First-line trastuzumab (H), oral vinorelbine (NVBo) and capecitabine (X) combination therapy for HER2-positive metastatic breast cancer (MBC): efficacy and safety in a multinational phase 2 studyPublication without faculty affiliation
- The Place of Chemotherapy in The Evolving Treatment Landscape for Patients With HR-positive/HER2-negative MBC2022 | First Faculty of Medicine
- High efficacy of the combination chemotherapy (CT) of oral vinorelbine (NVBO) and capecitabine (X) with trastuzumab (H) in HER2-positive metastatic breast cancer (MBC): updated analysis of the results of an international phase 2 trialPublication without faculty affiliation
- A Phase II Trial of Oral Vinorelbine and Capecitabine in Anthracycline Pretreated Patients with Metastatic Breast Cancer2009 | First Faculty of Medicine
- Multinational phase II study of navelbine (N) and herceptin (H) as first-line trerapy for HER2-overexpressing metastatic breast Cancer (HER2+MBC)Publication without faculty affiliation
- GLMM Based Clustering of Multivariate Mixed Type Longitudinal Data2022 | Faculty of Mathematics and Physics
- Long term survival of vinorelbine (N) and trastuzumab (H) as first line therapy for HER2-positive metastatic breast cancer patients (HER2+ MBC)Publication without faculty affiliation
- In vitro antibacterial activity of usnic acid and octyl gallate against resistant Enterococcus strains2014 | Publication without faculty affiliation
- Weekly trastuzumab (T) and paclitaxel (P) in metastatic breast cancer (MBC). The impact of taxane free interval (TFI) on treatment outcomePublication without faculty affiliation
- Avastin in first-line treatment of metastatic breast cancer - our experiences: case report2013 | Second Faculty of Medicine
- Trastuzumab deruxtekan2021 | First Faculty of Medicine
- Commentary on the 2021 ESMO guidelines for the treatment of metastatic breast cancer2022 | First Faculty of Medicine
- Defects in memory B-cell and plasma cell subsets expressing different immunoglobulin-subclasses in patients with CVID and immunoglobulin subclass deficiencies2019 | Second Faculty of Medicine
- Age-associated distribution of normal B-cell and plasma cell subsets in peripheral blood2018 | Second Faculty of Medicine
- Third consensus on medical treatment of metastatic breast cancer2009 | First Faculty of Medicine
- A Phase II Trial of Oral Vinorelbine and Capecitabine in Anthracycline Pretreated Patients with Metastatic Breast Cancer2009 | Central Library of Charles University
- Evaluating the impact of Relative Total Dose Intensity (RTDI) on patients' short and long-term outcome in taxane- and anthracycline-based chemotherapy of metastatic breast cancer- a pooled analysis2011 | First Faculty of Medicine
- A phase II trial of oral vinorelbine and capecitabine in anthracycline pretreated patients with metastatic breast cancer2009 | Central Library of Charles University
- A phase II trial of oral vinorelbine and capecitabine in anthracycline pretreated patients with metastatic breast cancer2009 | Faculty of Medicine in Pilsen
- A phase II trial of oral vinorelbine and capecitabine in anthracycline pretreated patients with metastatic breast cancer2009 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Gene expression profiling in circulating cells (CTCS) of breast carcinoma patientsPublication without faculty affiliation
- Strong antimicrobial activity of xanthohumol and other derivatives from hops (Humulus lupulus L.) on gut anaerobic bacteria2017 | Second Faculty of Medicine
- Circulating Tumor Cells in Patients with Breast Cancer: Monitoring Chemotherapy Success2014 | First Faculty of Medicine, Third Faculty of Medicine
- Phase II study on the efficacy and safety of Lapatinib administered beyond disease progression and combined with vinorelbine in HER-2/neu- positive advanced breast cancer: results of the CECOG LaVie trial2016 | First Faculty of Medicine
- Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer - Results of the eLEcTRA trial2012 | First Faculty of Medicine
- Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses2014 | First Faculty of Medicine
- The antibacterial effects of new N-Alkylpyridinium salts on planktonic and biofilm bacteria2020 | Publication without faculty affiliation
- Identification of Temporal Patterns in Income and LivingConditions of Czech Households: Clustering Based onMixed Type Panel Data from the EU-SILC Database2020 | Faculty of Mathematics and Physics
- Identification of Temporal Patterns in Income and Living Conditions of Czech Households: Clustering Based on Mixed Type Panel Data from the EU-SILC Database2020 | Faculty of Mathematics and Physics